Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$4.67 USD
+0.66 (16.46%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $4.99 +0.32 (6.85%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Prime Medicine, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PRME 4.67 +0.66(16.46%)
Will PRME be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRME based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRME
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates
Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy?
PRME: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Genomics Stocks Worth Adding to Your Portfolio in 2025
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
Other News for PRME
Upper Bollinger Band Walk appears for PRME after 1.47% move
NR7 appears for PRME after 0.25% move
Prime Drink Group Granted Extension for Financial Filings
Stochastic Sell Signal appears for PRME after 4.88% move
PRME forms Bearish Engulfing on September 10